1. The Oncotype DX® Breast test to guide management of nodepositive oestrogen receptor-positive HER2-negative breast cancer patients: the United Kingdom experience. (March 2019) Authors: Battisti, N.M.L.; Gutteridge, E.; Mylvaganam, S.; Parton, M.; Ring, A.; McGrath, S.E. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗